Initial Public Offerings – an inside view

Rolf J. Daxhammer; Andreas Resch; Oliver Schacht

doi:10.24053/9783739801735

Zusammenfassung

In a corporation’s financial life “going public” by means of an IPO is probably the single most important decision. It turns a private company into a public one. Our book will provide an inside view of the IPO process. On the one hand, it draws on the insights of an experienced investment banker, who has gone through numerous IPO transactions. On the other hand, it relates the story of an actual IPO through the eyes of a Chief Executive Officer who has taken two of his companies public. This unique double perspective is our book’s defining feature. We do not discuss initial public offerings in a textbook style fashion. What we would like to bring out is a more comprehensive portrayal of a “once-in-a-lifetime” event for most companies and their management, alike.

Publikation durchsuchen

Bibliographische Angaben

Copyrightjahr: 2018
ISBN-Print: 978-3-86764-739-7
ISBN-Online: 978-3-7398-0173-5
Verlag: uvk, Konstanz/München
Sprache: Deutsch
Seiten: 216
Produkttyp: Monographie

Inhaltsverzeichnis

KapitelSeiten

Titelei/Inhaltsverzeichnis Kein Zugriff Seiten 1 - 18
1. 1. 1. Why capital is needed Kein Zugriff
    2. Types of capital Kein Zugriff
    3. Characteristics of debt and equity capital Kein Zugriff
  2. 1. Internal and external financing and sources of capital Kein Zugriff
    2. Economic functions of financial markets Kein Zugriff
    3. Transformation task Kein Zugriff
  3. 1. Institutional set-up of Commercial Banking vs. Investment Banking Kein Zugriff
    2. Services offered in Investment Banking Kein Zugriff
    3. IPO as part of Investment Banking services Kein Zugriff
    4. Investment Banking in the US and Europe Kein Zugriff
  4. 1. Overview of international IPO activity Kein Zugriff
    2. Asia Kein Zugriff
    3. US Kein Zugriff
    4. Europe Kein Zugriff
    5. Future Prospects Kein Zugriff
2. 1. Advice Kein Zugriff
  2. Underwriting Kein Zugriff
  3. Distribution Kein Zugriff
  4. Post-IPO Kein Zugriff
3. 1. 1. Asset-based Approach Kein Zugriff
    2. Combined valuation methods Kein Zugriff
    3. Holistic valuation approaches Kein Zugriff
  2. 1. Estimating discount rates Kein Zugriff
    2. Measuring cash flows Kein Zugriff
    3. Forecasting cash flows Kein Zugriff
    4. Estimation of terminal value Kein Zugriff
  3. 1. Peer group Kein Zugriff
    2. Types of multiples Kein Zugriff
    3. Principles of relative valuation Kein Zugriff
1. 1. Access to public equity capital markets Kein Zugriff
  2. Capital structuring Kein Zugriff
  3. Offer structure: who sells how much stock at what price to whom? Kein Zugriff
  4. Use of proceeds (if any…) Kein Zugriff
  5. The real cost of capital in an IPO – fees & more Kein Zugriff
2. 1. Too many cooks? Kein Zugriff
  2. Best laid plans Kein Zugriff
  3. Timing is everything Kein Zugriff
  4. Once in a lifetime experience (except for some…) Kein Zugriff
3. 1. Corporate governance and compliance Kein Zugriff
  2. Management information & reporting systems Kein Zugriff
  3. Planning and ability to deliver on promises Kein Zugriff
  4. The Equity Story – giving a share a life of its own Kein Zugriff
4. 1. Media attention…there is no off the record Kein Zugriff
  2. Disclosure obligations Kein Zugriff
  3. Investor cheer & scrutiny & headaches Kein Zugriff
  4. Exit route “take private” Kein Zugriff
1. 1. The epigenomics IPO and its aftermath Kein Zugriff
  2. Considerations for Curetis when joining Kein Zugriff
  3. Growing Curetis and strategic options Kein Zugriff
  4. Change of heart, change of mind Kein Zugriff
2. 1. IFRS conversion and audits Kein Zugriff
  2. Non-deal roadshow, pilot fishing and test the waters Kein Zugriff
  3. Syndicate selection symphony Kein Zugriff
  4. Advisors and more Kein Zugriff
3. 1. Kick-off meeting Kein Zugriff
  2. Prospectus drafting and the AFM Kein Zugriff
  3. Due diligence delirium Kein Zugriff
  4. Analysts briefing and pre-IPO research 2015 vs. 2004 Kein Zugriff
  5. Price, place and packaging Kein Zugriff
4. 1. Start it off in the BeNeLux and France Kein Zugriff
  2. From London via Frankfurt to the USA Kein Zugriff
  3. The finish line in sight in London and Switzerland Kein Zugriff
  4. Roller coaster and the last 24 hours – build your own book Kein Zugriff
  5. Deal is done, let’s deal with it Kein Zugriff
5. 1. First day(s) of trading Kein Zugriff
  2. The quiet period Kein Zugriff
  3. Corporate governance and compliance mania Kein Zugriff
  4. Starting the IR song and dance Kein Zugriff
  5. Outlook (2016 and beyond), lock-up expiry and growth Kein Zugriff
Bibliography Kein Zugriff Seiten 209 - 216

Literaturverzeichnis (120 Einträge)

Part 1 Google Scholar öffnen
Altman, E. I., 1968. Financial Ratios, Discriminant Analysis and the Prediction of Corporate Bankruptcy. Journal of Finance, September, 23(4), pp. 589-609. Google Scholar öffnen doi.org/10.1111/j.1540-6261.1968.tb00843.x
Ballwieser, W., 2011. Unternehmensbewertung – Prozeß, Methoden und Probleme. Stuttgart: Schäffer-Poeschel Verlag. Google Scholar öffnen
Ballwieser, W., Beyer, S. & Zelger, H., 2005. Unternehmenskauf nach IFRS und US-GAAP. In: Impairment-Test nach IFRS und US-GAAP. Stuttgart: Ballwieser, Wolfgang; Beyer, Sven; Zelger, Hansjörg, pp. 191-223. Google Scholar öffnen
Black, F. & Scholes, M., 1972. The Pricing of Options and Corporate Liabilities. Journal of Political Economy, May – June, 81(3), pp. 637-654. Google Scholar öffnen
Bloomberg (2017). Global Capital Markets League Tables FY2016. Retrieved from: https://data. bloomberglp.com/professional/sites/4/Bloomberg-2016-Glb-CAPM-FINAL. pdf Google Scholar öffnen
Box, G., 2013. Time Series Analysis, Forecasting and Control. In: A Very British Affair. Houndmills(Basingstoke): Palgrave Macmillan UK, pp. 161-215. Google Scholar öffnen doi.org/10.1057/9781137291264_6
Brealey, R., Myers, S. & Allen, F., 2016. Principles of Corporate Finance. International Edition ed. New York: McGraw-Hill. Google Scholar öffnen
Burgstahler, D. & Dichev, I., 1997. Earnings Management to avoid Earnings Decreases and Losses. Journal of Accounting and Economics, 24(1), pp. 99-126. Google Scholar öffnen doi.org/10.1016/S0165-4101(97)00017-7
Campbell, J. Y. & Viceira, L. M., 2005. The Term Structure of the Risk-Return Trade-Off. Financial Analysts Journal, January/February, 61(1), pp. 34-44. Google Scholar öffnen doi.org/10.2469/faj.v61.n1.2682
Copeland, T., Koller, T. & Murrin, J., 2002. Unternehmenswert: Methoden und Strategien für eine wertorientierte Unternehmensführung. Frankfurt/Main: Campus Verlag. Google Scholar öffnen
Damodaran, A., 2012. Investment Valuation: Tools and Techniques for Determining the Value of any Asset. 3 ed. Hoboken(New Jersey): John Wiley & Sons. Google Scholar öffnen doi.org/10.1002/9781119201786
Damodaran, A., 2006. Damodaran on Valuation: Security Analisis for Investment and Corpor¬ate Finance. Hoboken(New Jersey): John Wiley & Sons. Google Scholar öffnen
Deutsche Welle (March 6, 2017). The rise and fall of the Schlecker empire. Retrieved from: http://www.dw.com/en/the-rise-and-fall-of-the-schlecker-empire/a-37824141 Google Scholar öffnen
Ernst, D., Schneider, S. & Thielen, B., 2012. Unternehmensbewertungen erstellen und ver¬stehen: Ein Praxisleitfaden. Müchen: Vahlen. Google Scholar öffnen
EY (2016). EY Global IPO Trends 2016 4Q. Retrieved from: www.ey.com/Publication/ vwLUAssets/ey-4q-2016-global-ipo-trends-report/$FILE/ey-4q-2016-global-ipo-trends-report.pdf Google Scholar öffnen
EY (2016). Anzahl der weltweiten Börsengänge in den Jahren von 2001 bis 2016. Retrieved from: https://de.statista.com/statistik/daten/studie/198574/umfrage/anzahl-der-boersen gaenge-weltweit-seit-1996/ Google Scholar öffnen
EY (2014). EY Global IPO Trends 2014 Q4. Retrieved from: http://www.ey.com/ Publication/vwLUAssets/ey-q4-14-global-ipo-trends-report/$FILE/ey-q4-14-global-ipo-trends-report.pdf Google Scholar öffnen
EY Transaction Advisory Services (2016). In: Valuation & Business Modeling. Stuttgart: Ernst & Young, pp. 99, 158 & 249. Google Scholar öffnen
Fama, E. F. & French, K. R., 2004. The Capital Asset Pricing Model: Theory and Evidence. Journal of Economic Perspectives, Summer, 18(3), pp. 25-46. Google Scholar öffnen doi.org/10.1257/0895330042162430
Fama, E. F., 1968. Risk, Return and Equilibrium: Some Clarifying Comments. Journal of Finance, 23(1), pp. 29-40. Google Scholar öffnen doi.org/10.1111/j.1540-6261.1968.tb02996.x
Financial Times (April 4, 2017). Convertible bonds catch a ride on equity rally. Retrieved from: https://www.ft.com/content/ee51a030-1893-11e7-9c35-0dd2cb31823a Google Scholar öffnen
Forbes (May 5, 2004). IPO Dutch Auctions vs. Traditional Allocation. Retrieved from: https://www.forbes.com/2004/05/10/cx_aw_0510mondaymatchup.html Google Scholar öffnen
Foster, G., 1977. Quarterly Accounting Data: Time-Series Properties and Predictive-Ability Results. The Accounting Review, January, 52(1), pp. 1-21. Google Scholar öffnen
Gordon, M. J., 1962. The Investment, Financing, and Valuation of the Corporation. 1 ed. Homewood: Richard D. Irwin. Google Scholar öffnen
Graham, J. R. & Harvey, C. R., 2001. The Theory and Practice of Corporate Finance: Evidence from the Field. Journal of Financial Economics, Volume 60, pp. 187-243. Google Scholar öffnen doi.org/10.1016/S0304-405X(01)00044-7
Graham, J. R. & Mills, L. F., 2008. Using Tax Return Data to Simulate Corporate Marginal Tax Rates. Journal of Accounting & Economics, December, 46(2), pp. 366-388. Google Scholar öffnen doi.org/10.1016/j.jacceco.2007.10.001
Graham, J. R., 1996. Proxies for the Corporate Marginal Tax Rate. Journal of Financial Economics, February, 42(2), pp. 187-221. Google Scholar öffnen doi.org/10.1016/0304-405X(96)00879-3
International Valuation Standards Council, 2016. IVS 105: Valuation Approaches and Methods, London: IVSC. Google Scholar öffnen
Investopedia (October 31, 2016). Violin Memory Now Trades on OTC Markets (VMEM). Retrieved from: http://www.investopedia.com/news/violin-memory-now-trades-otc-mar kets-vmem/ Google Scholar öffnen
Koller, T., Goedhart, M. H. & Wessels, D., 2010. Measuring and managing the value of companies. Hoboken, N.J.: John Wiley & Sons. Google Scholar öffnen
Little, I. M., 1962. Higgledy Piggledy Growth. Oxford Bulletin of Economics and Statistics, November, 24(4), pp. 387-412. Google Scholar öffnen doi.org/10.1111/j.1468-0084.1962.mp24004001.x
Lloyd’s (2017). Corporate History. Retrieved from: https://www.lloyds.com/lloyds/about-us/history/corporate-history Google Scholar öffnen
Mercer, Z. C. & Harms, T. W., 2008. Business Valuation: An Integrated Theory. Noboken(New Jersey): Wiley. Google Scholar öffnen
Nasdaq (2017). Offering History. Retrieved from: http://www.nasdaq.com/markets/ipos/offering-history.aspx?expert=self-underwritten Google Scholar öffnen
Nasdaq Globe Newswire (June 25, 2015). Molycorp Common Stock to Move to OTC Trading, Retrieved from: https://globenewswire.com/news-release/2015/06/25/747615/0/en/ Moly corp-Common-Stock-to-Move-to-OTC-Trading.html Google Scholar öffnen
New York Times (February 14, 2013). Berkshire and 3G Capital in a $23 Billion Deal for Heinz. Retrieved from: https://dealbook.nytimes.com/2013/02/14/berkshire-and-3g-capital-to-buy-heinz-for-23-billion/?_r=0 Google Scholar öffnen
New York Times (October 29, 1987). US Underwriters Face Losses on B.P. Offering. Retrieved from: http://www.nytimes.com/1987/10/29/business/us-underwriters-face-losses-on-bp-offering.html Google Scholar öffnen
Nwankwo, O. & Osho, S. G., 2010. An Empirical Analysis of Corporate Survival and Growth: Evidence from Efficient Working Capital Management. International Journal of Scholary Academic Intellectual Diversity, 12(1), p. 8 & 12. Google Scholar öffnen
PriceWaterhouseCoopers (2009). IPO Watch Europe – Review of the year 2009. Retrieved from: https://www.pwc.pl/pl/ipo-watch-europe/2009_summary.pdf Google Scholar öffnen
PWC (2011). Capital markets in 2025 – The future of equity capital markets. Retrieved from: https://www.pwc.com/gx/en/audit-services/publications/assets/capital_markets-the_futur e_of_equity_mrkts.pdf Google Scholar öffnen
Rosenbaum, J. & Pearl, J., 2013. Investment Banking: Valuation, Leveraged Buyouts, and Mergers & Acquisitions. 2 ed. Hoboken(New Jersey): Wiley. Google Scholar öffnen
Schira, J., 2012. Statistische Methoden der VWL und BWL: Theorie und Praxis. München: Pearson. Google Scholar öffnen
Sharpe, W. F., 1964. Capital Asset Prices: A Theory of Market Equilibrium under Conditions of Risk. Journal of Finance, September, Volume 19, pp. 425-442. Google Scholar öffnen
Stuart, T. E., 2000. Interorganizational Alliences and the Performance of Firms: A Study of Growth and Innovation Rates in a High-Technology Industry. Strategic Management Journal, 21(1), pp. 791-811. Google Scholar öffnen doi.org/10.1002/1097-0266(200008)21:8<791::AID-SMJ121>3.0.CO;2-K
Wöhe, G., Bilstein, J., Ernst, D. & Häcker, J., 2013. Grundzüge der Unternehmensfinanzierung. München: Vahlen. Google Scholar öffnen doi.org/10.15358/9783800645831-503
Part 2 Google Scholar öffnen
Bain & Company (2016) Global Private Equity Report 2016. Retrieved from: http://www.bain. com/bainweb/PDFs/Bain_and_Company_Global_Private_Equity_Report_2016.pdf (last visited 1 August 2016) Google Scholar öffnen
Brealey, R./Myers, S. (2000) Principles of Corporate Finance (Sixth Edition), Irwin/McGraw-Hill Google Scholar öffnen
Euromoney (2011) How do you fix the IPO market? Retrieved from: http://www.euromoney .com/Article/2877089/How-do-you-fix-the-IPO-market.html?p=1 (last visited on 4 August 2016) Google Scholar öffnen
Facebook, Inc. (2012) Prospectus for the public offering of 421,233,615 shares Class A common stock. Retrieved from: https://investor.fb.com/financials/sec-filings-details/default. aspx?Filing Id=8629552 (last visited on 14 June 2016) Google Scholar öffnen
IAS Plus, IAS 34 – Interim Financial Reporting. Retrieved from: http://www.iasplus.com/en/ standards /ias/ias34 (last visited on 28 June 2016) Google Scholar öffnen
J.P. Morgan (2014) Knocking on the door – Shareholder activism in Europe: Five things you need to know. Retrieved from: https://www.jpmorgan.com/jpmpdf/1320656894344.pdf (last visited 29 July 2016) Google Scholar öffnen
McKinsey Global Institute (2016) Diminishing Returns: Why Investors May Need to Lower Their Expectations. Retrieved from: http://www.mckinsey.com/industries/private-equity-and-prin cipal-investors/our-insights/why-investors-may-need-to-lower-their-sights (last visited on 25 July 2016) Google Scholar öffnen
McKinsey & Company (2014) Preparing for bigger, bolder shareholder activists. Retrieved from: http://www.mckinsey.com/business-functions/strategy-and-corporate-finance/our-insights /preparing-for-bigger-bolder-shareholder-activists (last visited on 26 July 2016) Google Scholar öffnen
MSCI (2016) Index Fact Sheet: MSCI AWCI IMI. Retrieved from: https://www.msci.com/ resources/factsheets /index_fact_sheet/msci-acwi-imi.pdf (last visited on 25 July 2016) Google Scholar öffnen
Practical Law (2016). Emerging Growth Company (EGC). Retrieved from: http://us.practicallaw.com/3-518-8137 (last visited on 21 July 2016) Google Scholar öffnen
PricewaterhouseCoopers (2016). Q2 2016 Equity Capital Markets Briefing. Retrieved from: https://www.pwc.de/de/newsletter/kapitalmarkt/assets/pwc-briefing-equity-capital-markets-q2-2016.pdf (last visited on 4 August 2016) Google Scholar öffnen
PricewaterhouseCoopers (2015). Considering an IPO? An insight into the costs post JOBS-Act. Retrieved from: https://www.pwc.com/us/en/deals/assets/ipo-costs-considerations-pwc-de als.pdf (last visited on 19 April 2016) Google Scholar öffnen
PricewaterhouseCoopers (2014). An overview of Russian IPOs: 2005 to 2014. Retrieved from: http://www.pwc.ru/en/capital-markets/publications/assets/a4_brochure_ipos_eng_print. pdf (last visited on 4 August 2016) Google Scholar öffnen
Rocket Internet AG (2014). Prospectus for the public offering of 32,941,177 new ordinary bearer shares with no par value. Retrieved from: https://www.rocket-internet.com/themes/ rocket3/download/ipo-history/Rocket%20Internet%20Prospectus.PDF (last visited on 6 June 2016) Google Scholar öffnen
Spiegel Online (2016). Ex-Chef Breuer zahlt 3,2 Millionen Euro an Deutsche Bank. Retrieved from: http://www.spiegel.de/wirtschaft/unternehmen/kirch-pleite-rolf-breuer-zahlt-3-2-mill ionen-euro-an-deutsche-bank-a-1084788.html (last visited on 19 July 2016) Google Scholar öffnen
Wall Street Journal (2012). Citi to Settle Suit for $590 Million. Retrieved from: http://www.wsj.com/articles/SB10000872396390444914904577619410325528148 (last visited on 25 July 2016) Google Scholar öffnen
Weil (2015). A Look At Sponsor-Backed Going Private Transactions. Retrieved from: http://peblog.wpengine.com/wp-content/uploads/2015/08/150482_Going_Private_Sur vey_2015_v21-Final. pdf (last visited on 1 August 2016). Google Scholar öffnen
Part 3 Google Scholar öffnen
4-traders (February 18, 2016). Curetis N.V: Appoints Bank Degroof Petercam SA as Liquidity rovider to Facililtate Trading on Euronext Brussels and Euronext Amsterdam. Google Scholar öffnen
Retrieved from: http://www.4-traders.com/CURETIS-N-V-24872715/news/Curetis-N-V-Appoints-BankDegroof-Petercam-SA-as-Liquidity-Provider-to-Facilitate-Trading-on-Euron-21872373/ Google Scholar öffnen
Alex Wilmerding, Term Sheets & Valuations, Aspatore Inc. 2003 Google Scholar öffnen
APA-OTS (January 11, 2011). EANS-News: Epigenomics Appoints Thomas Taapken as New CFO, Effective April 1, 2011. Retrieved from: http://www.ots.at/presseaussendung/OTE_2 0110111_OTE0002/eans-news-epigenomics-appoints-thomas-taapken-as-new-cfo-effective-april-1-2011 Google Scholar öffnen
Biocartis (April 24, 2015). Biocartis raises EUR 100 million in successful Initial Public Offering. Retrieved from: https://media.biocartis.com/biocartis-investors/documents/Biocartis_PR_I PO%20RESULT_20150424_ENG.pdf Google Scholar öffnen
Bionity (July 14, 2010). Curetis vervollständigt Aufsichtsrat und ernennt neuen CFO. Retrieved from: http://www.bionity.com/de/news/120022/curetis-vervollstaendigt-aufsichtsrat-und-ernennt-neuen-cfo.html Google Scholar öffnen
BioRegio STERN (October 28, 2011). Curetis AG gewinnt Forbion und Roche als neue Investoren. Retrieved from: http://www.bioregio-stern.de/de/aktuelles/aktuelles/curetis-ag-gewinn t-forbion-und-roche-als-neue-investoren Google Scholar öffnen
BioSpace (December 7, 2009). Life Sciences Partners leads € 18.5 million Series A Financing Round of Curetis. Retrieved from: http://www.biospace.com/News/life-sciences-partners-leads-18-5-million-series-a/164829 Google Scholar öffnen
Biospace (August 18, 2006). http://www.biospace.com/News/epigenomics-ag-announces-change-in-the-executive/27841 Google Scholar öffnen
CNN Money (September 22, 2015). Hillary Clinton tweet crushes biotech stocks. Retrieved from: http://money.cnn.com/2015/09/21/investing/hillary-clinton-biotech-price-gouging/ Google Scholar öffnen
Curetis (October 28, 2015). Curetis N.V. IPO Prospectus. Retrieved from: http://www.curetis.com/fileadmin/Dokumente/Downloads/Investors/Financial_Reports/Prospectus_Curetis_Printer.pdf Google Scholar öffnen
Curetis (2015). Financial Reports – IFRS 2012-2014. Retrieved from: http://www.curetis.com/fileadmin/Dokumente/Downloads/Investors/Financial_Reports/IFRS_2012-2014_Notes_20151022_FINAL.pdf Cited as: Curetis, 2015a Google Scholar öffnen
Curetis (2015). Financial Reports – IFRS 2015-06. Retrieved from: http://www.curetis.com/file admin/Dokumente/Downloads/Investors/Financial_Reports /IFRS_2015-06_ Notes_2 0151022_FINAL.pdf Cited as: Curetis, 2015b Google Scholar öffnen
Curetis (2015). Annual Report. Retrieved from: http://www.curetis.com/fileadmin/Dokumente/Investors/Annual_Report_2015_Approved.pdf Cited as: Curetis, 2015c Google Scholar öffnen
Curetis (November 10, 2015). Curetis IPO priced at EUR 10.00 per Share; raises EUR 40 million. Retrieved from: http://www.curetis.com/uploads/tx_news/Curetis_Pricing_PR_EN _10.11. 15_10pm_clean_01.pdf Cited as: Curetis, 2015e Google Scholar öffnen
Curetis (October 28, 2015). Curetis Announces its Initial Public Offering on Euronext in Amsterdam and Euronext in Brussels. Retrieved from: http://www.curetis.com/uploads /tx_news/IPO_Launch_Press_Release_Announcement_FINAL_English_27-10-15_01 .pdf Cited as: Curetis, 2015d Google Scholar öffnen
Die Welt (July 15, 2004). Ausgezeichneter Unternehmer. Retrieved from: https://www.welt.de/ print-welt/article327599/Ausgezeichneter-Unternehmer.html Google Scholar öffnen
Der Spiegel (August 5, 2004). „Man kommt sich vor wie der Betreiber eines Bordells“. Retrieved from: http://www.spiegel.de/wirtschaft/interview-mit-epigenomics-gruender-olek-man-kom mt-sich-vor-wie-der-betreiber-eines-bordells-a-311583.html Cited as: Der Spiegel, 2004b Google Scholar öffnen
Der Spiegel (February 4, 2004). Deutschlands beste Arbeitgeber. Retrieved from: http://www.spiegel.de/wirtschaft/capital-ranking-deutschlands-beste-arbeitgeber-a-284907. html Cited as: Der Spiegel, 2004a Google Scholar öffnen
DGP (October 14, 2015). IPO Research Initiation Note DGP – Roderick Verhelst Google Scholar öffnen
Epigenomics (March 30, 2010). http://www.epigenomics.com/wp-content/uploads/2016/03/ 20100510_3-Months_Report_2010_02.pdf Google Scholar öffnen
Epigenomics (2008). 3-Monatsbericht 2008 – Q1-2008. Retrieved from: http://www.epigenomics.com/news-investors/financial-reports/ Google Scholar öffnen
Epigenomics (September 12, 2001). Epigenomics CEO Alex Olek ist Deutschlands Entrepreneur des Jahres 2001. Retrieved from: http://www.epigenomics.com/news-investors/news-media/pressemitteilungen/archiv/article/epigenomics-ceo-alex-olek-ist-deutschlands-entrepren eur-des-jahres-2001.html Google Scholar öffnen
Enternext (2017). Curetis Price Chart. Retrieved from: https://www.enternext.biz/ Google Scholar öffnen
Euronext TV (November 11, 2015). Curetis celebrates dual listing on Euronext Amsterdam and Euronext Brussels. Retrieved from: https://www.youtube.com/watch?v=lriaeClJIiA Google Scholar öffnen
Finanznachrichten (2017). Epigenomics Chart. Retrieved from: http://www.finanznachrichten .de/chart-tool/aktie/epigenomics-ag.htm Google Scholar öffnen
Focus (November 10, 2015). Biotech-Firma Curetis schafft dank Bescheidenheit Börsengang. Retrieved from: http://www.focus.de/finanzen/news/wirtschaftsticker/ipo-biotech-firma-curetis-schafft-dank-bescheidenheit-boersengang_id_5077524.html Google Scholar öffnen
Forbion (November 24, 2014). Curetis Closes EUR 14.5 Million Extension to Series B Financing. Retrieved from: https://forbion.com/en/news/curetis_closes_eur_14_5_million_ex tension_to_series_b_financing Google Scholar öffnen
Forbion (April 23, 2013). Curetis raises EUR 12.5 million in Series B round. Retrieved from: https://forbion.com/en/news/curetis_raises_eur_12_5_million_in_series_b_round?page=5 Google Scholar öffnen
genomeweb (December 18, 2006). Roche's Termination of Epigenomics Alliance Topped Most-Read GenomeWeb News Stories Last Week. Retrieved from: https://www.genomeweb.com/ archive/roches-termination-epigenomics-alliance-topped-most-read-genomeweb-news-storie s- Google Scholar öffnen
Globenewswire (December 3, 2015). Retrieved from: http://inpublic.globenewswire.com/releaseDetails.faces?rId=1971191 Google Scholar öffnen
going public.de (November 12, 2015). Curetis feiert IPO in Amsterdam. Retrieved from: http://www.goingpublic.de/curetis-ag-feiert-gelungen-ipo-amsterdam Google Scholar öffnen
going public.de (March 24, 2004). IPO-Fehlstart, Teil II. Retrieved from: http://www.goingpublic.de/ipo-fehlstart-teil-ii Cited as: Going Public, 2004b Google Scholar öffnen
going public.de (March 17, 2004). Fehlstart in ein hoffnungsfrohes IPO-Jahr. Retrieved from: http://www.goingpublic.de/fehlstart-in-ein-hoffnungsfrohes-deutsches-ipo-jahr Cited as: Going Public, 2004a. Google Scholar öffnen
going public.de (February 23, 2004). IPO-Zitrone 2004... . Retrieved from: http://www.going public.de/ipo-zitrone-2004 Cited as: Going Public, 2004c Google Scholar öffnen
healthcare-in-europe.com (August 9, 2016). Curetis Acquires Rights to GEAR Database. Google Scholar öffnen
Retrieved from: http://www.healthcare-in-europe.com/en/article/17059-curetis-acquires-rights-to-gear-database.html Google Scholar öffnen
ICF (October 14, 2015). Investment Research Curetis NV, IPO Research Initiation Note ICF – Stefan Röhle Google Scholar öffnen
Independent Research (2015). Retrieved from: http://www.irffm.de/ Google Scholar öffnen
International Financial Law Review (2016). Frequently asked questions about Rule 144A. Retrieved from: http://www.iflr.com/pdfs/faqrule144a.pdf Google Scholar öffnen
Investment Europe (October 1, 2015). Bank Degroof and Petercam complete merger. Retrieved from: http://www.investmenteurope.net/regions/benelux/bank-degroof-and-petercam-com plete-merger/ Google Scholar öffnen
JMP Securities (2010). Charles Duncan, Molecular Diagnostics – Wall Street Perspective, Q3-2010. Retrieved from: https://quebecinternational.ca/media/280482/mdx%20presentation % 20october%202010.pdf Google Scholar öffnen
Labiotech (November 13, 2015). Curetis Molecular Diagnostics IPO Exceeds Expectations. Retrieved from: http://labiotech.eu/curetis-molecular-diagnostics-ipo-euronext-closed/ Google Scholar öffnen
Manager Magazin (July 8, 2004). “Sie müssen den Preis senken”. Retrieved from: http://www. manager-magazin.de/finanzen/artikel/a-307843.html. Google Scholar öffnen
Morgan Stanley, Dan Mahony, IPO Research initiation on ECX, July 2004 Google Scholar öffnen
Nasdaq Globe Newswire (December 13, 2016). Curetis Acquires Real-Time qPCR Platform from Carpegen and Systec. Retrieved from: https://globenewswire.com/news-release/2016/12/13/897061/0/en/Curetis-Acquires-Real-Time-qPCR-Platform-from-Carpegen-and-Systec.html Google Scholar öffnen
Niewiarra, K. and Segschneider, D., Balanceakt Compliance, Juli 2016, Frankfurter Allgemeine Buch Google Scholar öffnen
PR Newswire (December 18, 2000). Epigenomics Completes Its Merger with Orca Biosciences Creating the Industry's Leading Force in DNA Methylation Analysis Technologies. Retrieved from: http://www.prnewswire.com/news-releases/epigenomics-completes-its-merger-with-orca-biosciences-creating-the-industrys-leading-force-in-dna-methylation-analysis-technologi es-76235697.html Google Scholar öffnen
PwC, CMS, Curetis (March 3, 2016). Presentation at the Bio Deutschland CFO Gipfel, Eine Europäische Erfolgsstory – Curetis‘ IPO an der Euronext Google Scholar öffnen
RBC (October 14, 2015). Curetis N.V. – Made to Measure, IPO Research Initiation Note RBC – Nick Keher Google Scholar öffnen
Relationship Science (2015). Nick Kehrer. Retrieved from: https://relationshipscience.com/nick-keher-p5021660 Google Scholar öffnen
Reuters (January 20, 2007). Roche drops deal with biotech firm Epigenomics. Retrieved from: http://www.reuters.com/article/us-roche-epigenomics-idUSL1582576820061215 Google Scholar öffnen
Seeking Alpha (April 27, 2017). Epigenomics Goes Private. Retrieved from: https://seekingalpha.com/article/4065970-epigenomics-goes-private Google Scholar öffnen
The Wall Street Journal (July 27, 2015). Secret IPO Filings Feed Deal Frenzy. Retrieved from: https://www.wsj.com/articles/secret-ipo-filings-feed-deal-frenzy-1438039559 Google Scholar öffnen
VC Magazin (July 19, 2011). Trade Sale – Bis zu 190 Mio. EUR für mtm laboratories. Retrieved from: http://www.vc-magazin.de/news/bis-zu-190-mio-eur-fuer-mtm-laboratories/ Google Scholar öffnen